COVID-19 antiviral pills to be reserved primarily for the unvaccinated Despite TGA approval last month, the two new COVID-19 treatments developed by Pfizer and Merck will not be widely available for prescription in the short-term.
Study finds biofilm link to persistent wet cough in children Researchers hope the findings may lead to more effective treatments for protracted bacterial bronchitis and bronchiectasis.
Government spending on general practice surges Despite the funding rise general practice expenditure remains a fraction of the amount received by public hospitals.
Studies suggest vaccines cut long COVID symptoms Recent analysis from both the UK and Israel give positive signs for those with breakthrough infections, although Omicron is yet to be assessed.
Very few adverse reports for children’s vaccination Early data suggests COVID-19 vaccination is ‘well tolerated’ in children aged 5–11 with fewer adverse reactions reported.
GPs past and present honoured on Australia Day Sixteen GPs were recognised in the Australia Day Honours list for their contribution to medicine and society.
COVID vaccine deferral cut to four-month maximum ATAGI has changed its advice on temporary vaccine medical exemptions due to prior COVID-19 infections.
Study estimates 1.27m deaths due to antimicrobial resistance in 2019 More people died due to antimicrobial resistance in 2019 than the death toll from malaria and HIV combined, new research suggests.
Should Australia follow New Zealand’s lead on smoking? New plans could make it illegal for tobacco ever to be sold to anyone born after 2008. Two GPs consider whether Australia should follow suit.
Novavax approval: what it means for GPs The TGA’s Professor John Skerritt hopes the availability of the new vaccine will push the vaccination rate in Australia even higher.